Ingredients innovation company, Motif Ingredients, today announced it received $27.5 million in funding led by General Atlantic, a leading global growth equity firm, with participation from CPT Capital. The company also announces a rebranding with the new brand identity of Motif FoodWorks, alongside a number of additions to its leadership team.
Motif says it is pioneering the discovery of better ingredients that improve human health and animal welfare while reducing the environmental impact of animal agriculture. With the new funding, Motif plans to add to and accelerate its product pipeline; expand academic collaborations across a broad set of molecular food science disciplines; scale its science and regulatory staff; and deepen its research and development efforts as the company works to meet consumer demand for delicious, responsibly produced foods.
“Since launching the company we’ve seen an incredible response from the industry; it’s clear that the movement towards animal-free is no passing fad. Food leaders know that to get it right, however, there can be no compromise between taste and values,” said Jon McIntyre, CEO of Motif. “Our team of experienced scientists and passionate food lovers are working relentlessly to ensure our products — as well as our brand — deliver on that exciting and critical challenge.”
The new name also recognizes its technology partnership with Ginkgo Bioworks, a leading bioengineering platform, powering Motif’s ambition to reshape the landscape of food through science and technology.
As Motif enters its next phase of growth, the expansion of the executive and business development team underscores the company’s commitment to driving unprecedented R&D and product development. Motif has added three new senior management positions to its leadership team: Janet Collins joins as Head of Regulatory, Government and Industry Affairs, Julie Post-Smith as Director of Business Development and Morgan Keim as Business Development Manager. The company also announced that Peter Lafer, a Vice President at General Atlantic focused on life sciences investments in the firm’s global Healthcare sector, will join its Board as an observer.
“The momentum at Motif is palpable, and we have an exciting road ahead,” said McIntyre. “Powered with funds, technology and a team of incredibly talented food-lovers, we are moving closer to our mission to develop animal-free and plant-based ingredients that are more nutritious, more accessible and more sustainable for our planet.”
For more information about Motif FoodWorks, visit www.madewithmotif.com.
